CiMaas provides an attractive investment opportunity in a cellular immune-oncology field. At CiMaas, we are focused on bringing value to both our patients and our investors. Our vision is to create innovative treatments that will dramatically improve the lives of people living with cancer. At first through the use of natural killer cells and CAR-NK cells, we will revolutionise treatments and provide a safe and effective solution for fighting cancer.
Our cell therapy treatment utilizing natural killer cells is cutting-edge, and we are committed to providing the best possible outcomes for those we treat. We believe that by investing in our company, you are not only helping us to change the lives of those affected by cancer, but also supporting the development of lifesaving treatments that will benefit society.
The CiMaas Business Plan is available to interested investors.
For a video about CiMaas, click here (in Dutch)
Please contact us for further information.
You can also directly schedule an appointment .